BrilliA Inc (BRIA) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
BrilliA Inc stock (BRIA) is currently trading at $1.80. BrilliA Inc PE ratio is 15.33. BrilliA Inc PS ratio (Price-to-Sales) is 0.71. Analyst consensus price target for BRIA is $5.00. WallStSmart rates BRIA as Sell.
- BRIA PE ratio analysis and historical PE chart
- BRIA PS ratio (Price-to-Sales) history and trend
- BRIA intrinsic value — DCF, Graham Number, EPV models
- BRIA stock price prediction 2025 2026 2027 2028 2029 2030
- BRIA fair value vs current price
- BRIA insider transactions and insider buying
- Is BRIA undervalued or overvalued?
- BrilliA Inc financial analysis — revenue, earnings, cash flow
- BRIA Piotroski F-Score and Altman Z-Score
- BRIA analyst price target and Smart Rating
BrilliA Inc
📊 No data available
Try selecting a different time range
BRIA Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · BrilliA Inc (BRIA)
BRIA trades 159% above its Graham fair value of $0.82, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

Smart Analysis
BrilliA Inc (BRIA) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in return on equity, price/sales. Concerns around market cap and operating margin. Mixed signals suggest waiting for clearer direction before acting.
BrilliA Inc (BRIA) Key Strengths (2)
Paying less than $1 for every $1 of annual revenue
Every $100 of equity generates $22 in profit
Supporting Valuation Data
BrilliA Inc (BRIA) Areas to Watch (7)
Earnings declining -28.90%, profits shrinking
Very thin margins with limited operational efficiency
Very thin margins, barely profitable
Very low institutional interest at 0.00%
Micro-cap company with very limited liquidity and high volatility
Fairly priced relative to book value
Solid revenue growth at 13.80% per year
BrilliA Inc (BRIA) Detailed Analysis Report
Overall Assessment
This company scores 43/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 2 register as strengths (avg 9.5/10) while 7 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Return on Equity. Valuation metrics including Price/Sales (0.71) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 21.50%.
The Bear Case
The primary concerns are EPS Growth, Operating Margin, Profit Margin. Some valuation metrics including Price/Book (2.55) suggest expensive pricing. Growth concerns include Revenue Growth at 13.80%, EPS Growth at -28.90%, which may limit upside. Profitability pressure is visible in Operating Margin at 6.60%, Profit Margin at 4.37%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 21.50% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 13.80% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. EPS Growth and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
BRIA Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
BRIA's Price-to-Sales ratio of 0.71x sits near its historical average of 0.75x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 8% below its historical high of 0.78x set in Feb 2026, and 1% above its historical low of 0.71x in Mar 2026.
WallStSmart Analysis Synopsis
Data-driven financial summary for BrilliA Inc (BRIA) · CONSUMER CYCLICAL › APPAREL RETAIL
The Big Picture
BrilliA Inc is a mature, profitable business with steady cash generation. Revenue reached 64M with 14% growth year-over-year. Profit margins are strong at 437.0%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 2150.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Free cash flow is -5M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor APPAREL RETAIL industry trends, competitive moves, and regulatory changes that could impact BrilliA Inc.
Bottom Line
BrilliA Inc is a well-established business delivering consistent profitability with 437.0% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:27:45 AM
About BrilliA Inc(BRIA)
NYSE MKT
CONSUMER CYCLICAL
APPAREL RETAIL
USA
BrilliA Inc. is an innovative biotechnology company specializing in advanced skin health and regenerative medicine solutions. By harnessing proprietary technologies, BrilliA addresses significant unmet medical needs through the development of novel products aimed at enhancing wound healing and overall patient quality of life. With a robust emphasis on research and development, the company is well-positioned to translate scientific advancements into transformative therapeutic solutions, solidifying its leadership role in the evolving healthcare landscape.